Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres
Taro Koba,Yoshito Takeda,Ryohei Narumi,Takashi Shiromizu,Yosui Nojima,Mari Ito,Muneyoshi Kuroyama,Yu Futami,Takayuki Takimoto,Takanori Matsuki,Ryuya Edahiro,Satoshi Nojima,Yoshitomo Hayama,Kiyoharu Fukushima,Haruhiko Hirata,Shohei Koyama,Kota Iwahori,Izumi Nagatomo,Mayumi Suzuki,Yuya Shirai,Teruaki Murakami,Kaori Nakanishi,Takeshi Nakatani,Yasuhiko Suga,Kotaro Miyake,Takayuki Shiroyama,Hiroshi Kida,Takako Sasaki,Koji Ueda,Kenji Mizuguchi,Jun Adachi,Takeshi Tomonaga,Atsushi Kumanogoh
DOI: https://doi.org/10.1183/23120541.00658-2020
IF: 4.239
2021-01-01
ERJ Open Research
Abstract:There is an unmet need for novel biomarkers in the diagnosis of multifactorial COPD. We applied next-generation proteomics to serum extracellular vesicles (EVs) to discover novel COPD biomarkers. EVs from 10 patients with COPD and six healthy controls were analysed by tandem mass tag-based non-targeted proteomics, and those from elastase-treated mouse models of emphysema were also analysed by non-targeted proteomics. For validation, EVs from 23 patients with COPD and 20 healthy controls were validated by targeted proteomics. Using non-targeted proteomics, we identified 406 proteins, 34 of which were significantly upregulated in patients with COPD. Of note, the EV protein signature from patients with COPD reflected inflammation and remodelling. We also identified 63 upregulated candidates from 1956 proteins by analysing EVs isolated from mouse models. Combining human and mouse biomarker candidates, we validated 45 proteins by targeted proteomics, selected reaction monitoring. Notably, levels of fibulin-3, tripeptidyl-peptidase 2, fibulin-1, and soluble scavenger receptor cysteine-rich domain-containing protein were significantly higher in patients with COPD. Moreover, six proteins; fibulin-3, tripeptidyl-peptidase 2, UTP-glucose-1-phosphate uridylyl transferase, CD81, CD177, and oncoprotein-induced transcript 3, were correlated with emphysema. Upregulation of fibulin-3 was confirmed by immunoblotting of EVs and immunohistochemistry in lungs. Strikingly, fibulin-3 knockout mice spontaneously developed emphysema with age, as evidenced by alveolar enlargement and elastin destruction. We discovered potential pathogenic biomarkers for COPD using next-generation proteomics of EVs. This is a novel strategy for biomarker discovery and precision medicine.